Posted today on our “News and Events” is a recent report that high-dose statins carry a higher risk for the subsequent development of diabetes than lower dose statins. This information (read more...)
A meta-analysis of some of the more high-profile statin trials testing the effectiveness of high-dose therapy has revealed a significant increase [...]
The FDA has recently announced that simvastatin at the 80 mg dose should not be prescribed to new patients, and that those taking a lower dose of the drug should (read more...)
Recent articles in the media have cautioned the use of Niaspan ( a long acting preparation of Niacin) with Statins, raising concern over an increased risk of stroke, among other (read more...)